2/PORT Travel Controller
$750.00 Plus Shipping
The Travel System features a state-of-the-art 2/PORT Controller with Inlight Progressive Multi-Pulse™ technology.
FEATURES
- 2/PORT Traveler controller with Progressive Multi-Pulse™ technology
- 2 output ports powering up 2 interchangeable InLight polychromatic therapy pads
- Simply turn the device ON and enjoy the benefits of Progressive Multi-Pulse™ technology
- 7 manual setting options for professional applications
- 20-minute automatic session timer
- Illuminated sequencing display
- Durable, lightweight casing
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Take personal wellness to the next level. Perfectly designed and packaged for effective self-care at home and on the go! A state-of-the-art 2-port controller with Inlight Progressive Multi-Pulse™ technology.
Product Features
- 2/PORT Traveler controller with Progressive Multi-Pulse™ technology
- 2 output ports powering up 2 interchangeable Inlight polychromatic therapy pads
- Simply turn the device ON and enjoy the benefits of Progressive Multi-Pulse™ technology
- 7 manual setting options
- 20-minute automatic session timer
- Illuminated sequencing display
- Durable, lightweight casing
- Inlight Therapy System Power Supply. Good for any power anywhere in the world. Input 100-240V – 50-60Hz, 1.2A max. Output 12.0V, 5.0A.
- 6 foot AC power cord with 3-prong plug, NEMA 5-15P Connector, with C13 Connector that plugs into Power Supply.
Brands
In Light Therapy™
In Light Medical Systems™ provides a dynamic and user-friendly polychromatic light therapy system intended for clinical, professional and home user applications.
LED polychromatic light therapy involves the use of light emitting diodes (LED) delivering red, blue, and infrared light to the skin. These three (3) wavelengths stimulate beneficial innate cellular responses increasing circulation and activating the release of nitric oxide.Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.